Ursodeoxycholic Acid IP 300 mg
B2B catalogue entry for a tablet listed with ursodeoxycholic acid IP 300 mg; qualified buyers may request current pack and product documents, subject to applicability and availability.
Product gallery
Select an image to preview
Catalogue information
Catalogue data supports initial B2B identification only. Confirm every field against current, applicable product, market, and quality records before relying on it.
B2B catalogue verification
Reconcile this online entry with current, applicable documents before a purchasing, listing, or supply decision.
For identification only; not a controlled specification.
Confirm applicability and disclosure conditions for each requested record.
Official context
General references only; neither confirms this product's authorization or quality status.
This B2B catalogue entry is not patient guidance or prescribing information. It provides no indication, dose, administration, safety, storage, or availability advice. Use current approved product information and applicable records for professional purchasing and supply review.
Related Products
Gastroenterology / Hepatobiliary Care
Ursodeoxycholic Acid Sustained Release
B2B catalogue entry for a sustained-release tablet listed with ursodeoxycholic acid; current pack and product details may be requested for qualified review, subject to applicability and availability.
Gastroenterology / Antispasmodic
Mebeverine Hydrochloride Sustained Release
B2B catalogue entry for a sustained-release capsule listed with mebeverine hydrochloride; qualified buyers may request current product and market documents, subject to applicability and availability.
Gastroenterology / Antispasmodic
Mebeverine + Chlordiazepoxide
B2B catalogue entry for a tablet listed with mebeverine and chlordiazepoxide, presented for qualified product-document and trade inquiries.
Gastroenterology / Acidity & GERD
Esomeprazole (EC) + Domperidone (SR)
B2B catalogue entry for a capsule listed with enteric-coated esomeprazole and sustained-release domperidone, subject to document and market review.
Request Information
Tell us your organization, destination market, and the decision your request supports so applicability can be reviewed.